DendroTEK Biosciences
Synthetic, protease‑resistant cell‑culture matrix (dPGA) that boosts neuronal assay reliability.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $2.5M
AI Company Overview
Synthetic, protease‑resistant cell‑culture matrix (dPGA) that boosts neuronal assay reliability.
NeuroscienceCell Biology
Technology Platform
Dendritic polyglycerol amine (dPGA), a synthetic, cationic polymer coating that provides protease‑resistant, protein‑free surfaces for long‑term neuronal and other cell cultures.
Opportunities
Expansion into broader cell‑culture markets (cardiomyocytes, organoids) and strategic partnerships with organ‑on‑a‑chip and high‑throughput screening platforms.
Risk Factors
Dependence on a single product line and niche academic market; scaling manufacturing while maintaining GMP standards could be challenging.
Competitive Landscape
Competes with established coating suppliers (Corning, Thermo Fisher, Sigma) but differentiates through a fully synthetic, protein‑free, long‑stable polymer that improves assay reproducibility for advanced neuroscience models.